ERBB2 and breast cancer: Among breast cancers, the basal subtype, characterized by expression of markers such as cytokeratins 5 and 6 (61), had significantly higher repstress score compared with the luminal A, luminal B, and HER2-enriched subtypes (Fig. 4A).